NEW YORK, April 18, 2008 (Lawfuel) — The Brualdi Law Firm P.C.
announces that a class action has been commenced in the United States
District Court for the Northern District of Illinois on behalf of
purchasers of Walgreen Co. (“Walgreen” or the “Company”) (NYSE:WAG)
common stock during the period between June 25, 2007 and November 29,
2007 (the “Class Period”).

No class has yet been certified in the above action. If you are a
member of the proposed Class, you may, on or before June 14, 2008, ask
the Court to allow you to serve as lead plaintiff for the proposed
Class. To serve as a lead plaintiff, you must satisfy certain legal
requirements. In making your decision, you should take into account
that those with large financial losses resulting from the alleged
federal securities law violations are given preference in being
appointed lead plaintiff.

To be a member of the class you need not take any action at this time,
and you may retain counsel of your choice. If you wish to discuss this
action or have any questions concerning this Notice or your rights or
interests with respect to these matters, please contact Tali Leger,
Director of Shareholder Relations at The Brualdi Law Firm P.C., 29
Broadway, Suite 2400, New York, New York 10006, by telephone toll free
at (877) 495-1187 or (212) 952-0602, by email to
tleger@brualdilawfirm.com or visit our website at
http://www.brualdilawfirm.com/.

The complaint alleges that during the Class Period, Walgreen was
experiencing a steady decline in the growth of its core business —
filling retail drug prescriptions. Throughout the Class Period,
defendants failed to disclose declining growth rates for the Company’s
generic prescription business and misled investors concerning the
sustainability of Walgreen’s profits and sales. According to the
complaint, unbeknownst to Walgreen’s public shareholders, underlying
the erosion of Walgreen’s earnings was a material contract dispute with
one of the nation’s largest third-party providers of prescription drug
benefits — CVS Caremark (“Caremark”). During 2007, Walgreen disputed
Caremark’s reimbursement rates for a number of prescription drug plans
located primarily in the upper Midwestern U.S., which were negatively
impacting the Company’s earnings. On October 1, 2007, prior to the
market opening, Walgreen issued a press release announcing its
financial results for its fourth fiscal quarter and fiscal year 2006.
For the fourth quarter, the Company reported net income of $0.40 per
share — far below analysts’ earnings expectations of $0.47 per share.
In response to the announcement, the price of Walgreen stock declined
from $47.00 per share to $39.96 per share, on extremely heavy trading
volume.

Then, on November 29, 2007, Walgreen announced that “(a)fter many
months” of dispute with Caremark over the reimbursement rates for four
prescription plans, Walgreen withdrew as a pharmacy provider from the
plans. Following this announcement, shares of Walgreen common stock
declined to a new three-year low of $36.59 per share at the close of
trading on November 30, 2007.

SINGAPORE–LAWFUEL – The Law Newswire – April 18, 2008 – American lawyer Richard L. Cassin, founder of the popular online FCPA Blog, has published the first book about the Foreign Corrupt Practices Act (FCPA) that’s written in an informal and conversational style.

“There’s world-wide interest in the FCPA,” Cassin said, “and this book makes information about it accessible to anyone.”

The FCPA is the primary United States law against international public corruption. Because of its long reach, stiff penalties and recently stepped-up enforcement, it’s now one of the best-known and most feared white-collar criminal laws in the world.

Bribery Abroad has 35 easy-to-read chapters and an extensive topical index. It explains in non-technical language how companies and individuals can comply with the FCPA, and what to do if a violation happens. Topics also include legal defenses, noteworthy prosecutions, and recent developments in the global battle against public corruption.

Cassin has over 25 years experience dealing with the Foreign Corrupt Practices Act. He’s the founder of Cassin Law LLC, a law firm that helps American and other companies comply with United States laws.

“In my law practice, I encounter real people dealing with the Foreign Corrupt Practices Act in the real world,” Cassin said. “It’s not easy for them. That has shaped my view of the FCPA. And that’s what the book is about.”

Bribery Abroad is now available as a quality paperback or download at fcpablog.com and cassinlaw.com.

About Richard L. Cassin

Richard L. Cassin is an American lawyer and founder of the law firm Cassin Law LLC. He writes the online FCPA Blog, and his articles about law,business and corruption have appeared in the Wall Street Journal (Asia), Financial Times, Legal Times, Los Angeles Daily Journal, Business Times(Singapore), Oil and Gas Journal and Management World Magazine, among
others. From 1994 until 1998 he taught law part time at the National University of Singapore. He received his law degree from Boston College Law School, where he served as an editor of the Boston College Law Review. He’s a member of the bars in the District of Columbia, Virginia and Florida.

About Cassin Law LLC

Cassin Law LLC (cassinlaw.com) is an international law firm. It provides cost-effective and high-quality legal services to businesses of all sizes, from entrepreneurs to Fortune 500 companies.